Evidence map›Paper›PMID 40060945›Full record

ArticleFASEB bioAdvances2025

Inhibition of the Hippo pathway by verteporfin reduces the proliferation and stemness of rat hair follicle neural crest stem cells under hypoxia.

Weihai Liu, Suhua Chen, Xin Chen, Lixiang Xue, Yan Wang, Jun Yang

Abstract read
In one paragraph

Article in FASEB bioAdvances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Weihai LiuDepartment of Neurosurgery Peking University Third Hospital Beijing China.ORCID https://orcid.org/0009-0004-4312-7252
Suhua ChenDepartment of Neurosurgery Peking University Third Hospital Beijing China.
Xin ChenDepartment of Neurosurgery Peking University Third Hospital Beijing China.
Lixiang XueCenter of Basic Medical Research, Institute of Medical Innovation and Research Peking University Third Hospital Beijing China.
Yan WangCenter of Basic Medical Research, Institute of Medical Innovation and Research Peking University Third Hospital Beijing China.ORCID https://orcid.org/0000-0002-0066-6465
Jun YangDepartment of Neurosurgery Peking University Third Hospital Beijing China.ORCID https://orcid.org/0000-0001-9816-8108

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hair follicle neural crest stem cells reside in the bulge region of the outer root sheath of hair follicles, originate from the ectoderm, and have multidirectional differentiation potential, making them ideal candidates for tissue engineering applications. These cells mainly reside in a hypoxic microenvironment that favors the maintenance of stemness. Recently, many studies have elucidated the involvement of the Hippo pathway in the regulation of stem cell fate. However, few studies have investigated whether the Hippo signaling pathway regulates the growth of hair follicle neural crest stem cells in hypoxic environments. In the present study, we investigated the role of the Hippo pathway in the regulation of hair follicle neural crest stem cells under hypoxic conditions. We identified neural crest-derived stem cells from single-cell RNA-seq data of skin organoids in a public database, and reported that the Hippo pathway was activated in the cell population. Hair follicle neural crest stem cells were isolated from rat hair follicles and cultured under hypoxic (3% oxygen) and normoxic (20% oxygen) conditions. Cell viability was assessed via the CCK8 assay. The expression levels of several key genes, including

Indexed as

hair follicle stem cellHippo pathwayhypoxiastemnessverteporfin

Identifiers

PMID40060945
PMCPMC11886604

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.